CBL-514
N/A
Report date: 2026/04/15 20:02:38
NME
Base Information
Drug NameCBL-514
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCaliway Biopharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCaliway Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A